According to Latest Research, the global market for Human Leukocyte Antigen (HLA) Typing should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Human Leukocyte Antigen (HLA) Typing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Human Leukocyte Antigen (HLA) Typing market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Specialty Clinic grew percent.
Human leukocyte antigen (HLA) typing determines if patients and donors are compatible for cord blood or bone marrow transplants. Human leukocyte antigens (HLA) are proteins found in our bodies. The human immune system uses these markers to determine which cells belong in your body and which cells are foreign.
This report studies and analyses global Human Leukocyte Antigen (HLA) Typing status and future trends, helps the client to determine the Human Leukocyte Antigen (HLA) Typing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Human Leukocyte Antigen (HLA) Typing, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Human Leukocyte Antigen (HLA) Typing market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Human Leukocyte Antigen (HLA) Typing sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Human Leukocyte Antigen (HLA) Typing sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Human Leukocyte Antigen (HLA) Typing key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Human Leukocyte Antigen (HLA) Typing key producing regions, capacity, production, and year over year growth
(6) Human Leukocyte Antigen (HLA) Typing industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Thermo Fisher Scientific
QIAGEN
Illumina
CareDx
Immucor
Bio-Rad Laboratories, Inc
F. Hoffman-La Roche Ltd
Hologic, Inc
Luminex Corporation
Biofortuna
Bruker
Abbott
Takara Bio Inc
Omixon Inc
Siemens
EKF Diagnostics
BD
Fujirebio
TBG Diagnostics Limited
Market segment by Type, covers
Reagent
Instrument
Market segment by Application, can be divided into
Hospital
Specialty Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Human Leukocyte Antigen (HLA) Typing product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Human Leukocyte Antigen (HLA) Typing market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Human Leukocyte Antigen (HLA) Typing market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Human Leukocyte Antigen (HLA) Typing, percent & CAGR, 2018-2029
Chapter 5: Human Leukocyte Antigen (HLA) Typing industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Human Leukocyte Antigen (HLA) Typing Definition
1.2 Global Human Leukocyte Antigen (HLA) Typing Market Size and Forecast
1.2.1 By Consumption Value, Global Human Leukocyte Antigen (HLA) Typing Market Size,2018-2029
1.2.2 By Sales Quantity, Global Human Leukocyte Antigen (HLA) Typing Market Size,2018-2029
1.2.3 Global Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP),2018-2029
1.3 China Human Leukocyte Antigen (HLA) Typing Market Size and Forecast
1.3.1 By Consumption Value, China Human Leukocyte Antigen (HLA) Typing Market Size,2018-2029
1.3.2 By Sales Quantity, China Human Leukocyte Antigen (HLA) Typing Market Size,2018-2029
1.3.3 China Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP), 2018-2029
1.4 Share of China Human Leukocyte Antigen (HLA) Typing Market with Respect to the Global Market
1.4.1 By Consumption Value, China Human Leukocyte Antigen (HLA) Typing Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Human Leukocyte Antigen (HLA) Typing Market Share in Global, 2018-2029
1.4.3 Human Leukocyte Antigen (HLA) Typing Market Size: China VS Global, 2018-2029
1.5 Human Leukocyte Antigen (HLA) Typing Market Dynamics
1.5.1 Human Leukocyte Antigen (HLA) Typing Market Drivers
1.5.2 Human Leukocyte Antigen (HLA) Typing Market Restraints
1.5.3 Human Leukocyte Antigen (HLA) Typing Industry Trends
1.5.4 Human Leukocyte Antigen (HLA) Typing Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Human Leukocyte Antigen (HLA) Typing, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Human Leukocyte Antigen (HLA) Typing, Global Market Share by Company, 2018-2023
2.3 Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Human Leukocyte Antigen (HLA) Typing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Human Leukocyte Antigen (HLA) Typing Concentration Ratio
2.6 Global Human Leukocyte Antigen (HLA) Typing Mergers & Acquisitions, Expansion Plans
2.7 Global Human Leukocyte Antigen (HLA) Typing Manufacturers Product Type
2.8 Head Office and Human Leukocyte Antigen (HLA) Typing Production Site of Key Manufacturer
2.9 Human Leukocyte Antigen (HLA) Typing Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Human Leukocyte Antigen (HLA) Typing, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Human Leukocyte Antigen (HLA) Typing, China Market Share by Company, 2018-2023
3.3 China Human Leukocyte Antigen (HLA) Typing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Human Leukocyte Antigen (HLA) Typing Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Human Leukocyte Antigen (HLA) Typing Capacity by Region
4.3 Global Human Leukocyte Antigen (HLA) Typing Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Human Leukocyte Antigen (HLA) Typing Production by Region, 2018-2029
4.5 Global Human Leukocyte Antigen (HLA) Typing Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Human Leukocyte Antigen (HLA) Typing Industry Chain
5.2 Human Leukocyte Antigen (HLA) Typing Upstream Analysis
5.2.1 Human Leukocyte Antigen (HLA) Typing Core Raw Materials
5.2.2 Main Manufacturers of Human Leukocyte Antigen (HLA) Typing Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Human Leukocyte Antigen (HLA) Typing Production Mode
5.6 Human Leukocyte Antigen (HLA) Typing Procurement Model
5.7 Human Leukocyte Antigen (HLA) Typing Industry Sales Model and Sales Channels
5.7.1 Human Leukocyte Antigen (HLA) Typing Sales Model
5.7.2 Human Leukocyte Antigen (HLA) Typing Typical Distributors
6 Sights by Type
6.1 Human Leukocyte Antigen (HLA) Typing Classification
6.1.1 Reagent
6.1.2 Instrument
6.2 By Type, Global Human Leukocyte Antigen (HLA) Typing Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018-2029
6.4 By Type, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, 2018-2029
6.5 By Type, Global Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Human Leukocyte Antigen (HLA) Typing Segment by Application
7.1.1 Hospital
7.1.2 Specialty Clinic
7.1.3 Other
7.2 By Application, Global Human Leukocyte Antigen (HLA) Typing Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018-2029
7.4 By Application, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, 2018-2029
7.5 By Application, Global Human Leukocyte Antigen (HLA) Typing Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018-2029
8.3 By Region, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Human Leukocyte Antigen (HLA) Typing & Forecasts, 2018-2029
8.4.2 By Country, North America Human Leukocyte Antigen (HLA) Typing Market Size Market Share
8.5 Europe
8.5.1 Europe Human Leukocyte Antigen (HLA) Typing Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Human Leukocyte Antigen (HLA) Typing Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Human Leukocyte Antigen (HLA) Typing Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Human Leukocyte Antigen (HLA) Typing Market Size Market Share
8.7 South America
8.7.1 South America Human Leukocyte Antigen (HLA) Typing Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Human Leukocyte Antigen (HLA) Typing Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Human Leukocyte Antigen (HLA) Typing Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018-2029
9.3 By Country, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.4.2 By Type, U.S. Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.5.2 By Type, Europe Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.6.2 By Type, China Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.7.2 By Type, Japan Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.8.2 By Type, South Korea Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.10.2 By Type, India Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Human Leukocyte Antigen (HLA) Typing Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.1.2 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Thermo Fisher Scientific Company Profile and Main Business
10.1.5 Thermo Fisher Scientific Recent Developments
10.2 QIAGEN
10.2.1 QIAGEN Company Information, Head Office, Market Area, and Industry Position
10.2.2 QIAGEN Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.2.3 QIAGEN Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 QIAGEN Company Profile and Main Business
10.2.5 QIAGEN Recent Developments
10.3 Illumina
10.3.1 Illumina Company Information, Head Office, Market Area, and Industry Position
10.3.2 Illumina Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.3.3 Illumina Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Illumina Company Profile and Main Business
10.3.5 Illumina Recent Developments
10.4 CareDx
10.4.1 CareDx Company Information, Head Office, Market Area, and Industry Position
10.4.2 CareDx Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.4.3 CareDx Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 CareDx Company Profile and Main Business
10.4.5 CareDx Recent Developments
10.5 Immucor
10.5.1 Immucor Company Information, Head Office, Market Area, and Industry Position
10.5.2 Immucor Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.5.3 Immucor Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Immucor Company Profile and Main Business
10.5.5 Immucor Recent Developments
10.6 Bio-Rad Laboratories, Inc
10.6.1 Bio-Rad Laboratories, Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.6.3 Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Bio-Rad Laboratories, Inc Company Profile and Main Business
10.6.5 Bio-Rad Laboratories, Inc Recent Developments
10.7 F. Hoffman-La Roche Ltd
10.7.1 F. Hoffman-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.7.2 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.7.3 F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 F. Hoffman-La Roche Ltd Company Profile and Main Business
10.7.5 F. Hoffman-La Roche Ltd Recent Developments
10.8 Hologic, Inc
10.8.1 Hologic, Inc Company Information, Head Office, Market Area, and Industry Position
10.8.2 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.8.3 Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Hologic, Inc Company Profile and Main Business
10.8.5 Hologic, Inc Recent Developments
10.9 Luminex Corporation
10.9.1 Luminex Corporation Company Information, Head Office, Market Area, and Industry Position
10.9.2 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.9.3 Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Luminex Corporation Company Profile and Main Business
10.9.5 Luminex Corporation Recent Developments
10.10 Biofortuna
10.10.1 Biofortuna Company Information, Head Office, Market Area, and Industry Position
10.10.2 Biofortuna Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.10.3 Biofortuna Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Biofortuna Company Profile and Main Business
10.10.5 Biofortuna Recent Developments
10.11 Bruker
10.11.1 Bruker Company Information, Head Office, Market Area, and Industry Position
10.11.2 Bruker Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.11.3 Bruker Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Bruker Company Profile and Main Business
10.11.5 Bruker Recent Developments
10.12 Abbott
10.12.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.12.2 Abbott Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.12.3 Abbott Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Abbott Company Profile and Main Business
10.12.5 Abbott Recent Developments
10.13 Takara Bio Inc
10.13.1 Takara Bio Inc Company Information, Head Office, Market Area, and Industry Position
10.13.2 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.13.3 Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Takara Bio Inc Company Profile and Main Business
10.13.5 Takara Bio Inc Recent Developments
10.14 Omixon Inc
10.14.1 Omixon Inc Company Information, Head Office, Market Area, and Industry Position
10.14.2 Omixon Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.14.3 Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Omixon Inc Company Profile and Main Business
10.14.5 Omixon Inc Recent Developments
10.15 Siemens
10.15.1 Siemens Company Information, Head Office, Market Area, and Industry Position
10.15.2 Siemens Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.15.3 Siemens Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Siemens Company Profile and Main Business
10.15.5 Siemens Recent Developments
10.16 EKF Diagnostics
10.16.1 EKF Diagnostics Company Information, Head Office, Market Area, and Industry Position
10.16.2 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.16.3 EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 EKF Diagnostics Company Profile and Main Business
10.16.5 EKF Diagnostics Recent Developments
10.17 BD
10.17.1 BD Company Information, Head Office, Market Area, and Industry Position
10.17.2 BD Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.17.3 BD Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 BD Company Profile and Main Business
10.17.5 BD Recent Developments
10.18 Fujirebio
10.18.1 Fujirebio Company Information, Head Office, Market Area, and Industry Position
10.18.2 Fujirebio Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.18.3 Fujirebio Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Fujirebio Company Profile and Main Business
10.18.5 Fujirebio Recent Developments
10.19 TBG Diagnostics Limited
10.19.1 TBG Diagnostics Limited Company Information, Head Office, Market Area, and Industry Position
10.19.2 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
10.19.3 TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 TBG Diagnostics Limited Company Profile and Main Business
10.19.5 TBG Diagnostics Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Human Leukocyte Antigen (HLA) Typing Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Human Leukocyte Antigen (HLA) Typing Market Restraints
Table 3. Human Leukocyte Antigen (HLA) Typing Market Trends
Table 4. Human Leukocyte Antigen (HLA) Typing Industry Policy
Table 5. Global Human Leukocyte Antigen (HLA) Typing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Human Leukocyte Antigen (HLA) Typing Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Human Leukocyte Antigen (HLA) Typing Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Human Leukocyte Antigen (HLA) Typing Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Human Leukocyte Antigen (HLA) Typing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Human Leukocyte Antigen (HLA) Typing Mergers & Acquisitions, Expansion Plans
Table 12. Global Human Leukocyte Antigen (HLA) Typing Manufacturers Product Type
Table 13. Head Office and Human Leukocyte Antigen (HLA) Typing Production Site of Key Manufacturer
Table 14. Human Leukocyte Antigen (HLA) Typing Capacity of Major Manufacturers and Future Plan
Table 15. China Human Leukocyte Antigen (HLA) Typing Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Human Leukocyte Antigen (HLA) Typing Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Human Leukocyte Antigen (HLA) Typing Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Human Leukocyte Antigen (HLA) Typing Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Human Leukocyte Antigen (HLA) Typing Production by Region, 2018-2023, (K Units)
Table 20. Global Human Leukocyte Antigen (HLA) Typing Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Human Leukocyte Antigen (HLA) Typing Upstream (Raw Materials)
Table 22. Global Human Leukocyte Antigen (HLA) Typing Typical Customers
Table 23. Human Leukocyte Antigen (HLA) Typing Typical Distributors
Table 24. By Type, Global Human Leukocyte Antigen (HLA) Typing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Human Leukocyte Antigen (HLA) Typing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Human Leukocyte Antigen (HLA) Typing Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Human Leukocyte Antigen (HLA) Typing Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Human Leukocyte Antigen (HLA) Typing Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Human Leukocyte Antigen (HLA) Typing Sales Quantity Market Share, 2018-2029
Table 34. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
Table 35. Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 36. Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Thermo Fisher Scientific Company Profile and Main Business
Table 38. Thermo Fisher Scientific Recent Developments
Table 39. QIAGEN Company Information, Head Office, Market Area, and Industry Position
Table 40. QIAGEN Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 41. QIAGEN Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. QIAGEN Company Profile and Main Business
Table 43. QIAGEN Recent Developments
Table 44. Illumina Company Information, Head Office, Market Area, and Industry Position
Table 45. Illumina Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 46. Illumina Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Illumina Company Profile and Main Business
Table 48. Illumina Recent Developments
Table 49. CareDx Company Information, Head Office, Market Area, and Industry Position
Table 50. CareDx Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 51. CareDx Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. CareDx Company Profile and Main Business
Table 53. CareDx Recent Developments
Table 54. Immucor Company Information, Head Office, Market Area, and Industry Position
Table 55. Immucor Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 56. Immucor Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Immucor Company Profile and Main Business
Table 58. Immucor Recent Developments
Table 59. Bio-Rad Laboratories, Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 61. Bio-Rad Laboratories, Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bio-Rad Laboratories, Inc Company Profile and Main Business
Table 63. Bio-Rad Laboratories, Inc Recent Developments
Table 64. F. Hoffman-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 65. F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 66. F. Hoffman-La Roche Ltd Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. F. Hoffman-La Roche Ltd Company Profile and Main Business
Table 68. F. Hoffman-La Roche Ltd Recent Developments
Table 69. Hologic, Inc Company Information, Head Office, Market Area, and Industry Position
Table 70. Hologic, Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 71. Hologic, Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Hologic, Inc Company Profile and Main Business
Table 73. Hologic, Inc Recent Developments
Table 74. Luminex Corporation Company Information, Head Office, Market Area, and Industry Position
Table 75. Luminex Corporation Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 76. Luminex Corporation Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Luminex Corporation Company Profile and Main Business
Table 78. Luminex Corporation Recent Developments
Table 79. Biofortuna Company Information, Head Office, Market Area, and Industry Position
Table 80. Biofortuna Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 81. Biofortuna Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Biofortuna Company Profile and Main Business
Table 83. Biofortuna Recent Developments
Table 84. Bruker Company Information, Head Office, Market Area, and Industry Position
Table 85. Bruker Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 86. Bruker Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Bruker Company Profile and Main Business
Table 88. Bruker Recent Developments
Table 89. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 90. Abbott Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 91. Abbott Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Abbott Company Profile and Main Business
Table 93. Abbott Recent Developments
Table 94. Takara Bio Inc Company Information, Head Office, Market Area, and Industry Position
Table 95. Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 96. Takara Bio Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Takara Bio Inc Company Profile and Main Business
Table 98. Takara Bio Inc Recent Developments
Table 99. Omixon Inc Company Information, Head Office, Market Area, and Industry Position
Table 100. Omixon Inc Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 101. Omixon Inc Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Omixon Inc Company Profile and Main Business
Table 103. Omixon Inc Recent Developments
Table 104. Siemens Company Information, Head Office, Market Area, and Industry Position
Table 105. Siemens Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 106. Siemens Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Siemens Company Profile and Main Business
Table 108. Siemens Recent Developments
Table 109. EKF Diagnostics Company Information, Head Office, Market Area, and Industry Position
Table 110. EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 111. EKF Diagnostics Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. EKF Diagnostics Company Profile and Main Business
Table 113. EKF Diagnostics Recent Developments
Table 114. BD Company Information, Head Office, Market Area, and Industry Position
Table 115. BD Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 116. BD Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. BD Company Profile and Main Business
Table 118. BD Recent Developments
Table 119. Fujirebio Company Information, Head Office, Market Area, and Industry Position
Table 120. Fujirebio Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 121. Fujirebio Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Fujirebio Company Profile and Main Business
Table 123. Fujirebio Recent Developments
Table 124. TBG Diagnostics Limited Company Information, Head Office, Market Area, and Industry Position
Table 125. TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Models, Specifications, and Application
Table 126. TBG Diagnostics Limited Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. TBG Diagnostics Limited Company Profile and Main Business
Table 128. TBG Diagnostics Limited Recent Developments
List of Figures
Figure 1. Human Leukocyte Antigen (HLA) Typing Picture
Figure 2. Global Human Leukocyte Antigen (HLA) Typing Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Human Leukocyte Antigen (HLA) Typing Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Human Leukocyte Antigen (HLA) Typing Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Human Leukocyte Antigen (HLA) Typing Sales Quantity (K Units) & (2018-2029)
Figure 7. China Human Leukocyte Antigen (HLA) Typing Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Human Leukocyte Antigen (HLA) Typing Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Human Leukocyte Antigen (HLA) Typing Market Share of Global, 2018-2029
Figure 10. Global Human Leukocyte Antigen (HLA) Typing Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Human Leukocyte Antigen (HLA) Typing Key Participants, Market Share, 2022
Figure 12. Global Human Leukocyte Antigen (HLA) Typing Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Human Leukocyte Antigen (HLA) Typing Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Human Leukocyte Antigen (HLA) Typing Production Market Share & Forecast by Region, 2018-2029
Figure 15. Human Leukocyte Antigen (HLA) Typing Industry Chain
Figure 16. Human Leukocyte Antigen (HLA) Typing Pro
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|